Related Experiment Video
Updated: Feb 20, 2026
10:35
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
37.3K
Developing a xenograft human tumor model in immunocompetent mice
Matthew T Basel1, Sanjeev Narayanan2, Chanran Ganta2
1Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
Cancer Letters
|October 22, 2017
Summary
Researchers developed a novel immunocompetent xenograft model by inducing fetal tolerance to human tumor cells in mice. This breakthrough advances cancer research by enabling studies of immune system interactions with therapies.
Area of Science:
- Oncology
- Immunology
- Animal Models
Background:
- Current animal models for cancer research, particularly xenografts, lack functional immune systems, limiting their translational value.
- Understanding tumor-immune interactions is crucial for developing effective cancer therapies.
Purpose of the Study:
- To establish a functional xenograft tumor model in immunocompetent mice.
- To overcome the limitations of traditional xenografts by incorporating a murine immune system.
Main Methods:
- Murine fetuses (at embryonic day 14) were injected with A375 human melanoma cells to induce immune tolerance.
- Postnatal mice were challenged with A375 cells to assess tumor development and metastasis.
- Human tumor origin was confirmed using immunohistochemistry and PCR.
Main Results:
- Intravenous injection of human tumor cells into tolerized immunocompetent mice resulted in the formation of metastatic-like lung tumors.
- The established model successfully replicated results with various human tumor types, including pancreatic, breast, melanoma, and cervical adenocarcinomas.
- Tumors were confirmed to be of human origin.
Conclusions:
- A novel method for creating immunocompetent xenograft tumor models in mice was successfully developed.
- This model allows for the investigation of human tumor and immune system interactions.
- The model holds significant potential for preclinical cancer research and patient-derived xenograft studies, particularly in evaluating therapeutic responses.
